Evidence map›Paper›PMID 32367046›Full record

ArticleNature cell biology2020

In vitro capture and characterization of embryonic rosette-stage pluripotency between naive and primed states.

Alex Neagu, Emiel van Genderen, Irene Escudero, Lucas Verwegen, Dorota Kurek, Johannes Lehmann, Jente Stel, René A M Dirks, Guido van Mierlo, Alex Maas and 12 more

Open access · greenAbstract read
PubMed Publisher
In one paragraph

Article in Nature cell biology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 85 papers.

0numbers the graph read from it
0cells of the map it votes in
85citing papers in PubMed
7.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

85 citing papers in PubMed, 135 citations in OpenAlex.

  1. The making of cells and organs in xenogeneic animal bioreactor.Signal transduction and targeted therapy · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Pluripotent cell states and fates in human embryo models.Development (Cambridge, England) · 2025
    Review

25 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

22 authors at 5 institutions in 4 countries.

Alex Neagu *Department of Cell Biology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Emiel van Genderen *Department of Cell Biology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Irene Escudero *Department of Cell Biology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Lucas VerwegenDepartment of Cell Biology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Dorota KurekDepartment of Cell Biology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Johannes LehmannDepartment of Cell Biology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Jente StelDepartment of Cell Biology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
René A M DirksDepartment of Molecular Biology, Faculty of Science, Radboud University, Radboud Institute for Molecular Life Sciences (RIMLS), Nijmegen, The Netherlands.ORCID http://orcid.org/0000-0002-3093-5662
Guido van MierloDepartment of Molecular Biology, Faculty of Science, Radboud University, Radboud Institute for Molecular Life Sciences (RIMLS), Nijmegen, The Netherlands.ORCID http://orcid.org/0000-0001-5883-0339
Alex MaasDepartment of Cell Biology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Cindy EleveldDivision of Reproductive Medicine, Department of Obstetrics and Gynaecology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Yang GeDepartment of Cell Biology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.ORCID http://orcid.org/0000-0001-7667-5459
Alexander T den DekkerCenter for Biomics, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Rutger W W BrouwerCenter for Biomics, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
Wilfred F J van IJckenCenter for Biomics, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.ORCID http://orcid.org/0000-0002-0421-8301
Miha ModicThe Francis Crick Institute, London, UK.
Micha DrukkerInstitute of Stem Cell Research, Helmholtz Zentrum München, Neuherberg, Germany.
Joop H JansenDepartment of Laboratory Medicine, Laboratory of Hematology, Radboud University, Nijmegen Medical Centre and Radboud Institute for Molecular Life Sciences (RIMLS), Nijmegen, The Netherlands.
Nicolas C RivronInstitute of Molecular Biotechnology of the Austrian Academy of Sciences, Vienna Biocenter (VBC), Vienna, Austria.
Esther B BaartDivision of Reproductive Medicine, Department of Obstetrics and Gynaecology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.ORCID http://orcid.org/0000-0002-2611-3148
Hendrik MarksDepartment of Molecular Biology, Faculty of Science, Radboud University, Radboud Institute for Molecular Life Sciences (RIMLS), Nijmegen, The Netherlands.ORCID http://orcid.org/0000-0002-4198-3731
Derk Ten BergeDepartment of Cell Biology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands. d.tenberge@erasmusmc.nl.ORCID http://orcid.org/0000-0002-5863-0860
Erasmus MC · NLRadboud University Nijmegen · NLHelmholtz Zentrum München · DEInstitute of Molecular Biotechnology · ATThe Francis Crick Institute · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Following implantation, the naive pluripotent epiblast of the mouse blastocyst generates a rosette, undergoes lumenogenesis and forms the primed pluripotent egg cylinder, which is able to generate the embryonic tissues. How pluripotency progression and morphogenesis are linked and whether intermediate pluripotent states exist remain controversial. We identify here a rosette pluripotent state defined by the co-expression of naive factors with the transcription factor OTX2. Downregulation of blastocyst WNT signals drives the transition into rosette pluripotency by inducing OTX2. The rosette then activates MEK signals that induce lumenogenesis and drive progression to primed pluripotency. Consequently, combined WNT and MEK inhibition supports rosette-like stem cells, a self-renewing naive-primed intermediate. Rosette-like stem cells erase constitutive heterochromatin marks and display a primed chromatin landscape, with bivalently marked primed pluripotency genes. Nonetheless, WNT induces reversion to naive pluripotency. The rosette is therefore a reversible pluripotent intermediate whereby control over both pluripotency progression and morphogenesis pivots from WNT to MEK signals.

Indexed as

AnimalsBlastocystCell DifferentiationChromatinEmbryonic Stem CellsFemaleGene Expression Regulation, DevelopmentalGerm LayersMaleMiceMice, Inbred C57BLMorphogenesisOtx Transcription FactorsPluripotent Stem CellsChromatinOtx Transcription Factors

Identifiers

PMID32367046
OpenAlexW3023198889

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.